SCHEMBL2896147

SCHEMBL2896147

NC(=O)C1CC(=O)NC1=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.47
APEX1 P27695 1/20 0.47
KMT2A Q03164 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
MAP3K14 Q99558 1/20 0.43
ALDH1A1 P00352 2/20 0.42
CYP19A1 P11511 1/20 0.37
CRBN Q96SW2 3/20 0.36
DDB1 Q16531 2/20 0.35
RGS12 O14924 1/20 0.31
TSHR P16473 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.30
ITGB3 P05106 1/20 0.30
ITGB2 P05107 1/20 0.30
ITGB1 P05556 1/20 0.30
ITGAV P06756 1/20 0.30
ITGA2B P08514 1/20 0.30
ITGA5 P08648 1/20 0.30
ITGB5 P18084 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21658858 0.81 MAP3K14 (0.46) MEN1APEX1KMT2ATDP1L3MBTL1
SCHEMBL2711511 0.79 MAP3K14 (0.44) MEN1APEX1KMT2ATDP1L3MBTL1
SCHEMBL514603 0.79 ALDH1A1 (0.52) MEN1APEX1KMT2ATDP1L3MBTL1
SCHEMBL23855133 0.78 CRBN (0.50) MEN1APEX1KMT2ATDP1L3MBTL1
SCHEMBL27553051 0.77 MAP3K14 (0.43) MEN1APEX1KMT2ATDP1L3MBTL1
SCHEMBL6511682 0.77 MAP3K14 (0.43) MEN1APEX1KMT2ATDP1L3MBTL1
SCHEMBL4941968 0.77 MAP3K14 (0.39) MEN1APEX1KMT2ATDP1L3MBTL1
Cyclopropane SCHEMBL15636563 0.76 ALDH1A1 (0.49) MEN1APEX1KMT2ATDP1L3MBTL1
SCHEMBL8100037 0.74 MAP3K14 (0.40) MEN1APEX1KMT2ATDP1L3MBTL1
SCHEMBL19953555 0.74 ALDH1A1 (0.73) ALDH1A1TSHRSMN1; SMN2LMNAIDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019179928-A1 SUBSTITUTED SUCCINIMIDE-3-CARBOXAMIDES, SALTS THEREOF AND THE USE THEREOF AS HERBICIDAL AGENTS BAYER AKTIENGESELLSCHAFT (DE) 2019-09-26 WO claimed
CN-110734796-B Fuel soluble synergistic cleaning mixture for high pressure gasoline engines 雅富顿化学公司 2023-04-14 CN disclosed
WO-2021252859-A1 INHIBITORS OF APOL1 AND USE OF THE SAME VERTEX PHARMACEUTICALS INCORPORATED (US) 2021-12-16 WO disclosed
EP-3334721-B1 CGRP RECEPTOR ANTAGONISTS LILLY CO ELI (US) 2021-04-28 EP disclosed
CN-107922385-B CGRP receptor antagonists 伊莱利利公司 2020-09-08 CN disclosed
CN-111500329-A Fuel additive mixture providing rapid injector cleaning in high pressure gasoline engines 雅富顿化学公司 2020-08-07 CN disclosed
WO-2019179928-A1 SUBSTITUTED SUCCINIMIDE-3-CARBOXAMIDES, SALTS THEREOF AND THE USE THEREOF AS HERBICIDAL AGENTS BAYER AKTIENGESELLSCHAFT (DE) 2019-09-26 WO disclosed
WO-2019179928-A1 SUBSTITUTED SUCCINIMIDE-3-CARBOXAMIDES, SALTS THEREOF AND THE USE THEREOF AS HERBICIDAL AGENTS BAYER AKTIENGESELLSCHAFT (DE) 2019-09-26 WO disclosed
US-9708297-B2 CGRP receptor antagonists ELI LILLY AND COMPANY (US) 2017-07-18 US disclosed
US-20170044138-A1 CGRP RECEPTOR ANTAGONISTS ELI LILLY AND COMPANY 2017-02-16 US disclosed
US-20090031614-A1 Environmentally-Friendly Fuel Compositions AFTON CHEMICAL CORPORATION 2009-02-05 US disclosed
US-20060168876-A1 Fuels compositions and methods for using same AFTON CHEMICAL CORPORATION 2006-08-03 US disclosed
US-20050066572-A1 Fuels compositions and methods for using same AFTON CHEMICAL CORPORATION 2005-03-31 US disclosed
EP-1518918-A1 Fuels compositions and methods for using same Afton Chemical Corporation (US) 2005-03-30 EP disclosed
CN-1184195-C Succinimide-acid compound and its derivative ETHYL CORP (US) 2005-01-12 CN disclosed
US-6548458-B2 Prepared by reaction of hydrocarbyl-substituted succinic acylating agents with alpha-omega amino acids; pendant carboxylic acid moieties can be reacted with amines, alkoxylated amines and polyols; fuel additives ETHYL CORPORATION 2003-04-15 US disclosed
US-20020091068-A1 Succinimide-acid compounds and derivatives thereof AFTON CHEMICAL INTANGIBLES LLC 2002-07-11 US disclosed
CN-1322712-A Succinimide-acid compound and its derivative ETHYL CORP (US) 2001-11-21 CN disclosed
EP-1151994-A1 Succinimide-acid compounds and derivatives thereof ETHYL CORPORATION (US) 2001-11-07 EP disclosed
US-4057432-A PHOTOGRAPHIC COUPLERS KONISHIROKU PHOTO INDUSTRY CO., LTD. (JA) 1977-11-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020091068-A1 Succinimide-acid compounds and derivatives thereof SCD, DSG1, ELOVL1 MEN1 3582/4885APEX1 2327/4885KMT2A 1351/4885
US-20170044138-A1 CGRP RECEPTOR ANTAGONISTS CALCRL, CALCR, CCKBR MEN1 1975/4885APEX1 4525/4885KMT2A 3881/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.